Methylglyoxal downregulates Raf-1 protein through a ubiquitination-mediated mechanism

International Journal of Biochemistry and Cell Biology

Volumn 38, Issue 7, 2006, Pages 1084-1091

  Du, Jun ^a   Zeng, Jun ^a   Ou, Xueling ^a   Ren, Xianda ^b   Cai, Shaohui ^b  

^a Center of Microbiology   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Methylglyoxal; Phosphorylation; Raf 1; Ubiquitination

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; BISINDOLYLMALEIMIDE; METHYLGLYOXAL; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C INHIBITOR; RAF PROTEIN; RAS PROTEIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; OXIDATION; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

CELL CULTURE TECHNIQUES; DIABETES COMPLICATIONS; DOWN-REGULATION; HUMANS; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-RAF; PYRUVALDEHYDE; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; UBIQUITIN-ACTIVATING ENZYMES;

EID: 33645861371     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2005.10.019     Document Type: Article

References (26)

1. Blank M., Mandel M., Keisari Y., Meruelo D., and Lavie G. Enhanced ubiquitinylation of heat shock protein 90 as a potential mechanism for mitotic cell death in cancer cells induced with hypericin. Cancer Research 63 (2003) 8241-8247
2. Bonvini P., Dalla Rosa H., Vignes N., and Rosolen A. Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldanamycin: role of the co-chaperone carboxyl heat shock protein 70-interacting protein. Cancer Research 64 (2004) 3256-3264
3. Demand J., Alberti S., Patterson C., and Hohfeld J. Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling. Current Biology 11 (2001) 1569-1577
4. Dent P., Haser W., Haystead T.A., Vincent L.A., Roberts T.M., and Sturgill T.W. Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257 (1992) 1404-1407
5. Waf1/Cip1 signal transduction pathway in inhibition of IGF-I-mediated cell growth response by methylglyoxal. Journal of Cellular Biochemistry 88 (2003) 1235-1246
6. Du J., Suzuki H., Nagase F., Akhand A.A., Ma X.Y., Yokoyama T., et al. Superoxide-mediated early oxidation and activation of ASK1 are important for initiating methylglyoxal-induced apoptosis process. Free Radical Biology and Medicine 31 (2001) 469-478
7. Du J., Suzuki H., Nagase F., Akhand A.A., Yokoyama T., Miyata T., et al. Methylglyoxal induces apoptosis in Jurkat leukemia T cells by activating c-Jun N-terminal kinase. Journal of Cellular Biochemistry 77 (2000) 333-344
8. Howe L.R., Leevers S.J., Gomez N., Nakielny S., Cohen P., and Marshall C.J. Activation of the MAP kinase pathway by the protein kinase Raf. Cell 71 (1992) 335-342
9. Kalapos M.P. Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications. Toxicology Letters 110 (1999) 145-175
10. Kolch W., Heidecker G., Kochs G., Hummel R., Vahidi H., Mischak H., et al. Protein kinase C an activates Raf-1 by direct phosphorylation. Nature 364 (1993) 249-252
11. Lin Y.W., Chuang S.M., and Yang J.L. ERK1/2 achieves sustained activation by stimulating MAPK phosphatase-1 degradation via the ubiquitin-proteasome pathway. The Journal of Biological Chemistry 278 (2003) 21534-21541
12. Manenti S., Delmas C., and Darbon J.M. Cell adhesion protects c-Raf-1 against ubiquitin-dependent degradation by the proteasome. Biochemical and Biophysical Research Communications 294 (2002) 976-980
13. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80 (1995) 179-185
14. Munch G., Shepherd C.E., McCann H., Brooks W.S., Kwok J.B., Arendt T., et al. Intraneuronal advanced glycation endproducts in presenilin-1 Alzheimer's disease. Neuroreport 13 (2002) 601-604
15. Portero-Otin M., Pamplona R., Bellmunt M.J., Ruiz M.C., Prat J., Salvayre R., et al. Advanced glycation end product precursors impair epidermal growth factor receptor signaling. Diabetes 51 (2002) 1535-1542
16. Pratt W.B. The Hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proceedings of the Society for Experimental Biology and Medicine 217 (1998) 420-434
17. Rofina J.E., Singhm K., Skoumalova-Vesela A., Ederen A.M., Asten A.J., Wilhelm J., et al. Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine. Amyloid 11 (2004) 90-100
18. Satish K.M., Mrudulam T., Mitram N., and Bhanuprakash Reddy G. Enhanced degradation and decreased stability of eye lens alpha-crystallin upon methylglyoxal modification. Experimental Eye Research 79 (2004) 577-583
19. Schneider C., Sepp-Lorenzino L., Nimmesgern E., Ouerfelli O., Danishefsky S., Rosen N., et al. Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90. Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 14536-14541
20. Schulman B.A., Carrano A.C., Jeffrey P.D., Bowen Z., Kinnucan E.R., Finnin M.S., et al. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature 408 (2000) 381-386
21. Schulte T.W. Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association. The Journal of Biological Chemistry 270 (1995) 24585-24588
22. Takemoto D.J. Decreases in Raf-1 levels in galactosemic lens epithelial cells are partially reversed by myo-inositol. Acta Diabetologica 35 (1998) 145-149
23. Thornalley P.J. The glyoxalase system in health and disease. Molecular Aspects of Medicine 14 (1993) 287-371
24. Thornalley P.J. Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-a role in pathogenesis and antiproliferative chemotherapy. General Pharmacology 27 (1996) 565-573
25. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. The Journal of Biological Chemistry 266 (1991) 15771-15781
26. Zatechka Jr. D.S., Kador P.F., Garcia-Castineiras S., and Lou M.F. Diabetes can alter the signal transduction pathways in the lens of rats. Diabetes 52 (2003) 1014-1022